Skip to main content
. 2016 Dec 14;6(1):12–19. doi: 10.1080/21623945.2016.1271511

Figure 3.

Figure 3.

Canofin and Lysyl oxidase propeptide (LOX-PP) similarly inhibited AKT phosphorylation and promoted PPARγ expression. (A) LOX-PP and canofin, a peptide competitive inhibitor of FGF-2 receptor, inhibited AKT signaling; (B) LOX-PP and canofin abolished the inhibitory effects of FGF-2 on PPARγ expression. (Means ± SEM; **P < 0.01)